1. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial. Issue 3 (15th May 2012) Authors: Tak, Paul P; Balanescu, Andra; Tseluyko, Vira; Bojin, Silvia; Drescher, Edit; Dairaghi, Dan; Miao, Shichang; Marchesin, Vittorio; Jaen, Juan; Schall, Thomas J; Bekker, Pirow Journal: Annals of the rheumatic diseases Issue: Volume 72:Issue 3(2013) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗